You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 6, December 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aggravation of Broad-β Disease (Type 3 Hyperlipoproteinemia) by Hypothyroidism

William R. Hazzard, MD; Edwin L. Bierman, MD

Arch Intern Med. 1972;130(6):822-828.


Abstract

A man with peripheral atherosclerosis manifested concurrent postsurgical hypothyroidism and braod-β disease (type 3 hyperlipoproteinemia). In the presence of both, low-density lipoprotein levels remained normal, but very low-density lipoprotein (VLDL) levels were markedly increased, β-migrating, and rich in cholesterol. During replacement therapy with levothyroxine, cholesterol and triglyceride levels were initially reduced to normal, and the diagnosis of broad-β disease became uncertain. Its persistence was suggested by the relative prominence of Sf12-100 lipoproteins, the cholesterol-rich composition of VLDL subfractions and of chylomicrons persisting late after an orally administered fat load, the preponderance of slower-migrating lipoproteins in the Sf20-60 subfraction. With time, moderate hyperlipoproteinemia returned, and broad-β disease was again clearly evident. Thus, secondary factors may interact with the primary metabolic defect to influence the chemical, and possibly clinical, expression of broad-β disease.



Author Affiliations

Seattle

From the Department of Medicine, University of Washington School of Medicine, and Veterans Administration Hospital, Seattle.


Footnotes

Received for publication April 5, 1972; accepted April 28.

Reprint requests to 4435 Beacon Ave S, Seattle 98108 (Dr. Hazzard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Expression of Type III Hyperlipoproteinemia in Apolipoprotein E2 (Arg158->Cys) Homozygotes Is Associated With Hyperinsulinemia
de Beer et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:294-299.
ABSTRACT | FULL TEXT  

A young man with dry skin and nodules on elbows and buttocks
Kashyap and Kashyap
Postgrad. Med. J. 2000;76:109-111.
FULL TEXT  

Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment
BREWER et al.
ANN INTERN MED 1983;98:623-640.
ABSTRACT  

Broad-{beta} Disease (Type III Hyperlipoproteinemia) in a Large Kindred: Evidence for a Monogenic Mechanism
HAZZARD et al.
ANN INTERN MED 1975;82:141-146.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.